Oman vs Puerto Rico: Cancer death rate by age group
Oman
0 deaths per 100,000 people
in 2021
Puerto Rico
0 deaths per 100,000 people
in 2022
Oman rank
77th
Puerto Rico rank
77th
Cancer death rate by age group over time
- Oman
- Puerto Rico
How they compare
Oman currently reports 0 deaths per 100,000 people against 0 deaths per 100,000 people in Puerto Rico, a difference of 0 deaths per 100,000 people.
The two have swapped places 3 times across 6 shared years of data; in 2009 it was Oman ahead.
Oman ranks 77th and Puerto Rico ranks 77th of 111 countries.
Across the 3 decades both report, Oman averaged higher in 1 and Puerto Rico in 1.
Head to head by decade
| Decade | Oman | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.2 deaths per 100,000 people | 0 deaths per 100,000 people | 3.2 deaths per 100,000 people | Oman |
| 2010s | 0.6339 deaths per 100,000 people | 1.34 deaths per 100,000 people | 0.7098 deaths per 100,000 people | Puerto Rico |
| 2020s | 0 deaths per 100,000 people | 0 deaths per 100,000 people | 0 deaths per 100,000 people | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cancer death rate by age group, Oman or Puerto Rico?
- Oman, at 0 deaths per 100,000 people against 0 deaths per 100,000 people in Puerto Rico as of 2021.
- What is the difference in cancer death rate by age group between Oman and Puerto Rico?
- 0 deaths per 100,000 people, with Oman ahead.
- How many years of comparable data are there for Oman and Puerto Rico?
- 6 years are reported by both, from 2009 to 2021.
- How do Oman and Puerto Rico rank globally for cancer death rate by age group?
- Oman ranks 77th and Puerto Rico ranks 77th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Cancer death rate by age group. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from malignant neoplasms per 100,000 people in both sexes aged less than 1 year.